The company is evaluating the launch of an asset-backed securities program, which would involve issuing a single class of securities backed by assets related to its subsidiary, Shenzhen Hengyu Lianxiang Investment Development Co., Ltd. These underlying assets primarily consist of a real estate building currently held by Hengyu and located in Futian District, Shenzhen, China, which is presently occupied by the group's Shenzhen Zhongshan Hospital.

The planned ABS are intended to be listed and traded on the Shanghai Stock Exchange. If this proposed transaction is successfully completed, it is anticipated to significantly reduce the company's existing leverage ratio while optimizing its capital structure and asset quality.

Should the company proceed with the proposed transaction, it may constitute a deemed disposal of Hengyu under Rule 14.29 of the Hong Kong Stock Exchange's Listing Rules. The company intends to apply in due course to the relevant regulatory authorities, including but not limited to the China Securities Regulatory Commission, the Shanghai Stock Exchange, and the Hong Kong Stock Exchange, for the necessary approvals related to the proposed transaction.

As of the date of this announcement, the specific details and terms of the proposed transaction have not yet been finalized.